Alnylam Pharmaceuticals Inc (ALNY)
150.41
-0.96
(-0.63%)
USD |
NASDAQ |
May 10, 16:00
151.04
+0.63
(+0.42%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Return Price: 150.41 for May 10, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
May 09, 2024 | 151.37 |
May 08, 2024 | 152.29 |
May 07, 2024 | 154.33 |
May 06, 2024 | 151.22 |
May 03, 2024 | 152.33 |
May 02, 2024 | 150.31 |
May 01, 2024 | 149.96 |
April 30, 2024 | 143.95 |
April 29, 2024 | 147.36 |
April 26, 2024 | 143.31 |
April 25, 2024 | 143.71 |
April 24, 2024 | 143.80 |
April 23, 2024 | 146.07 |
April 22, 2024 | 145.79 |
April 19, 2024 | 144.41 |
April 18, 2024 | 145.16 |
April 17, 2024 | 145.32 |
April 16, 2024 | 146.72 |
April 15, 2024 | 147.70 |
April 12, 2024 | 148.50 |
April 11, 2024 | 152.09 |
April 10, 2024 | 152.41 |
April 09, 2024 | 155.90 |
April 08, 2024 | 156.04 |
April 05, 2024 | 153.56 |
Date | Value |
---|---|
April 04, 2024 | 151.48 |
April 03, 2024 | 150.83 |
April 02, 2024 | 151.04 |
April 01, 2024 | 153.33 |
March 28, 2024 | 149.45 |
March 27, 2024 | 154.39 |
March 26, 2024 | 151.97 |
March 25, 2024 | 152.07 |
March 22, 2024 | 146.51 |
March 21, 2024 | 146.62 |
March 20, 2024 | 147.99 |
March 19, 2024 | 148.17 |
March 18, 2024 | 147.41 |
March 15, 2024 | 149.27 |
March 14, 2024 | 148.53 |
March 13, 2024 | 148.42 |
March 12, 2024 | 146.65 |
March 11, 2024 | 149.10 |
March 08, 2024 | 149.82 |
March 07, 2024 | 149.86 |
March 06, 2024 | 149.66 |
March 05, 2024 | 149.68 |
March 04, 2024 | 150.04 |
March 01, 2024 | 152.61 |
February 29, 2024 | 151.09 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
65.86
Minimum
May 20 2019
241.31
Maximum
Dec 21 2022
155.72
Average
152.89
Median
Feb 24 2022
Total Return Price Benchmarks
Ionis Pharmaceuticals Inc | 39.09 |
Pfizer Inc | 28.02 |
Blueprint Medicines Corp | 106.66 |
BridgeBio Pharma Inc | 29.09 |
Madrigal Pharmaceuticals Inc | 205.43 |